THE GENERAL HOSPITAL CORPORATION EXCLUSIVE PATENT LICENSE AGREEMENT MGH Agreement No: A212814 MGH Case No: 2562 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED...Exclusive Patent License Agreement • August 14th, 2014 • ProQR Therapeutics B.V. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 14th, 2014 Company Industry JurisdictionThis Exclusive Patent License Agreement (together with all accompanying Exhibits, collectively the “Agreement”) is made as of the 29th day of May, 2012 (“Effective Date”), by and between ProQR Therapeutics B.V., a private partnership organized and existing under the laws of The Netherlands, and having a principal place of business at Darwinweg 24, 2333CR Leiden, The Netherlands (“Company”) and The General Hospital Corporation, d/b/a Massachusetts General Hospital, a not-for-profit Massachusetts corporation, with a principal place of business at 55 Fruit Street, Boston, Massachusetts 02114 (“Hospital”), each referred to herein individually as a “Party” and collectively as the “Parties”.
SUBLEASE OF OFFICE ACCOMMODATION (the “Agreement”) and other commercial accommodation within the meaning of Article 7:230a of the Dutch Civil CodeSublease Agreement • August 14th, 2014 • ProQR Therapeutics B.V. • Pharmaceutical preparations
Contract Type FiledAugust 14th, 2014 Company IndustryThis translation can only be used in combination with and as explanation to the Dutch text. In the event of a disagreement or dispute relating to the interpretation of the English text the Dutch text will be binding. These general conditions are subject to Dutch law.
AGREEMENT CONCERNING SUBLEASESublease Agreement • August 14th, 2014 • ProQR Therapeutics B.V. • Pharmaceutical preparations
Contract Type FiledAugust 14th, 2014 Company IndustryProQR Therapeutics B.V. (PROQR) is a biotech startup with the need for business premises and laboratory facilities. PROQR wishes to sublease the business premises with access to laboratory facilities of MicroSafe Laboratories until 31 December 2013, with an option for 2014.